Furthermore, the results of an m6A dot blot assay indicated that global m6A levels were clearly increased, alongside the high expression of METTL3, in CRC tissues, suggesting that m6A levels are increased in human CRC. This evidence concerns the gene METTL3 and colorectal carcinoma.